EX-23.2 5 petx-20170804xex23_2.htm EX-23.2 Exhibit 232

Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



We hereby consent to the incorporation by reference in this Registration Statement on Form S‑3 of our report dated March 14, 2017 relating to the financial statements, which appears in Aratana Therapeutics, Inc.'s Annual Report on Form 10‑K for the year ended December 31, 2016.  We also consent to the reference to us under the heading “Experts” in such Registration Statement. 



/s/ PricewaterhouseCoopers LLP
Boston, MA
August 4, 2017